Gyrus-backed Essential Pharma completes two deals
- Essential Pharma has sold its oral liquid portfolio to Inflexion-backed Rosemont Pharmaceuticals.
- Essential has separately acquired a series of Rosemont’s products as part of its geographic expansion plan.